These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8768342)

  • 1. Polypharmacy side effects.
    Markowitz J; Patrick K
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):842. PubMed ID: 8768342
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular effects of methylphenidate.
    Daniels SR
    J Pediatr; 2009 Jul; 155(1):A3. PubMed ID: 19559283
    [No Abstract]   [Full Text] [Related]  

  • 3. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

  • 4. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extreme reduction of methylphenidate levels by carbamazepine.
    Behar D; Schaller J; Spreat S
    J Am Acad Child Adolesc Psychiatry; 1998 Nov; 37(11):1128-9. PubMed ID: 9808919
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulants and neuroleptic withdrawal dyskinesia.
    Connor DF
    J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):247-8. PubMed ID: 9519625
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoxetine-imipramine interaction.
    Leroi I; Walentynowicz MA
    Can J Psychiatry; 1996 Jun; 41(5):318-9. PubMed ID: 8793156
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylphenidate and chromosome damage.
    Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K
    Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate.
    Lewis BR; Aoun SL; Bernstein GA; Crow SJ
    J Child Adolesc Psychopharmacol; 2001; 11(2):193-8. PubMed ID: 11436960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
    Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulants for ADHD in child patients with Tourette's syndrome: the issue of relative risk.
    Gadow KD; Sverd J
    J Dev Behav Pediatr; 1990 Oct; 11(5):269-71; discussion 272. PubMed ID: 1979565
    [No Abstract]   [Full Text] [Related]  

  • 12. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Killeen MR
    J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
    [No Abstract]   [Full Text] [Related]  

  • 13. Sudden death of a child treated with imipramine. Case study.
    Varley CK
    J Child Adolesc Psychopharmacol; 2000; 10(4):321-5. PubMed ID: 11191693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy and EPS in a child; a case report.
    Tahiroglu AY; Avci A
    Psychopharmacol Bull; 2007; 40(2):129-33. PubMed ID: 17514191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of imipramine-associated immune thrombocytopenia.
    Aksoy A; Erduran E; Gedik Y
    Turk J Pediatr; 2009; 51(3):275-8. PubMed ID: 19817272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
    Pelz R; Banaschewski T; Becker K
    Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary analysis of interactive effects between common classroom contingencies and methylphenidate.
    Northup J; Jones K; Broussard C; DiGiovanni G; Herring M; Fusilier I; Hanchey A
    J Appl Behav Anal; 1997; 30(1):121-5. PubMed ID: 9157096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
    Olders H
    J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
    [No Abstract]   [Full Text] [Related]  

  • 20. Dose-proportional and stereospecific pharmacokinetics of methylphenidate delivered using an osmotic, controlled-release oral delivery system.
    Modi NB; Wang B; Noveck RJ; Gupta SK
    J Clin Pharmacol; 2000 Oct; 40(10):1141-9. PubMed ID: 11028253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.